VEDA VYAS: Open Payments
NPI 1417052309 · WINTER PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 44 payments from 8 companies in 2025. Trend: 2023 $649 · 2024 $1,101 · 2025 $1,308
Food & beverage: $1,196Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 22 | $622 |
| Teva Pharmaceuticals USA, Inc. | 6 | $317 |
| Otsuka America Pharmaceutical, Inc. | 6 | $140 |
| Axsome Therapeutics, Inc. | 4 | $122 |
| Lundbeck LLC | 2 | $42 |
| ABBVIE INC. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Tris Pharma Inc | 1 | $16 |
Products named: INGREZZA, AUSTEDO XR, REXULTI, Auvelity, VRAYLAR, ABILIFY ASIMTUFII, COBENFY, Onyda XR.
Industry payments across FL — which companies pay providers there.
